Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants

Status unconfirmed · Phase 4

Conditions studied: Catheterization

In brief

The purpose of this study is to prevent catheter-related infections in newborn infants admitted to the Neonatal Intensive Care Unit (NICU). This study will compare the effectiveness of daily chlorhexidine versus isopropyl alcohol in preventing the growth of microbes in catheters.

Key facts

Study ID

NCT00516360

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

150

Starts

2007-07-01

Expected to finish

2008-08-01

Last updated by the study team

2008-05-30

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Admitted to the NICU
• Umbilical vein catheter or peripherally inserted central venous catheter (PICC) anticipated to be in place for more than 48 hours
• Parent or guardian able to give informed consent prior to first hyperalimentation and total parenteral nutrition tubing change

You may not qualify if…

• Known CRBSI-positive blood culture at the time of catheter line placement.
• Not expected to survive for more than 48 hours
• Broviac or any other surgically-placed central catheters
• Any condition that, as determined by the investigator, would interfere with evaluation of the line or be a potential health risk to the participant

Where it is running

• University of Rochester — Rochester, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.